Removing 10% of a patient's blood before major liver surgery and giving it back afterwards reduced transfusions by half, according to a large clinical trial published in The Lancet Gastroenterology & ...
Molecular subtypes and outcomes in regorafenib-treated patients with metastatic colorectal cancer (mCRC) enrolled in the CORRECT trial. Effects of regorafenib (REG) therapy on health-related quality ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback